Medical Cannabis

Josh Crossney is the columnist and editor of “Cannabis Crossroads” and a contributing editor to 

 magazine. Crossney is also the president and CEO of Cannabis Science Conference. Direct correspondence to:


Articles

Dr. Denise Vidot shares some of her research findings that examine the impact of phytocannabinoids on multiple diseases.

Exploring the Impact of Cannabis on the Human Brain, Heart, and Gut

In this piece, we touch on the benefits and challenges associated with autoflowering genetics, and provide justification for why these unique varietals may be the catalyst for making cannabis medicine more accessible and approachable for the general population. 

Autoflowering Genetics Present Unique Opportunities

Medical cannabis patients and adult-use consumers alike are faced with an overwhelming amount of options when they first enter a dispensary. Across the industry, producers are looking for ways to simplify things for consumers. One company, Volunteer Botanicals, recently partnered with an investment group to create cannabidiol (CBD)-based tablets that also combine other cannabinoids and have the potential to create a unique consumer experience. In this interview, Jason Pickle, co-founder and chief sales officer for Volunteer Botanicals, sits down to discuss this recent product, the need for standardization throughout the cannabis industry, and more.

How the Cannabis Market Can Expand with Innovative Products Like CBD Instant Release Tablets

Society’s ability to treat medical conditions is intimately tied to the extent of its knowledge and use of science and technology. No doubt, we’ve come a long way over the millennia. On the other hand, we still have so far to go.

Transitioning to 21st Century Medicine: The Promise of Whole Plant Medicine

The partnership will focus on sharing patient and advocate experiences and educating the public on the medical benefits of cannabis.

Cannabis Patient Care™ and Americans for Safe Access Form Partnership

The Cannabis Center of Excellence, Inc., Medicinal Genomics, and UMass Dartmouth  have established the Healthcare Provider Knowledge, Attitudes, Practices Related to Medical Cannabis Research Study to help better understand the experiences of healthcare providers have seen with medical cannabis.

Healthcare Provider-Focused Medical Cannabis Research Study Launched by Cannabis Center of Excellence, Medicinal Genomics, and UMass Dartmouth

In this interview, learn about Nicole DiMonda’s incredible story and Jaime Brambila’s research efforts to document her case and help the lives of other cancer patients.

Medical Cannabis as an Adjunct Therapy to  Cancer Treatment: One Patient’s Journey from Diagnosis to Remission

Congress passes the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act and the Medical Marijuana Research Act in two historic votes, signifying a growing shift toward cannabis legalization.

Congress Passes Two Historic Cannabis Reform Bills

United Nations hold historic vote announcing cannabis's Schedule IV removal from the 1961 Single Convention on Narcotics.

United Nations Removes Cannabis from Schedule IV Category

The proceeds raised from the special Veterans Day webcast will help support the families of America's fallen military heroes.